[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ca19-9-antigen":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CA19-9 Antigen",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06050252","Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery",[11],"Phase 2","RECRUITING","2026-08-26T02:16:33.772093Z","2026-07-05T05:32:16.740055Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05679674","Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer",[],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:29.193858Z"]